{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.526.3.1442","meta":{"versionId":"20","lastUpdated":"2021-01-15T13:04:49.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"American Academy of Ophthalmology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-01-15"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1442","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.526.3.1442"}],"version":"20170823","name":"UseOfSystemicSympatheticAlpha1AAntagonistMedicationForTreatmentOfProstaticHypertrophy","title":"Use of Systemic Sympathetic alpha-1a Antagonist Medication for Treatment of Prostatic Hypertrophy","status":"active","experimental":false,"date":"2017-08-23T01:00:04-04:00","publisher":"American Academy of Ophthalmology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This value set contains concepts that represent systemic sympathetic alpha-1a antagonist medications for treatment of prostatic hypertrophy.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; oral administrations of alfuzosin hydrochloride, doxazosin, prazosin, and terazosin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1611"]}]},"expansion":{"identifier":"urn:uuid:6ac1e4d0-315f-422c-b18e-0d3684a2b215","timestamp":"2023-12-11T02:56:19-05:00","total":23,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197625","display":"doxazosin 1 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197626","display":"doxazosin 2 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197627","display":"doxazosin 4 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197628","display":"doxazosin 8 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"198141","display":"prazosin 5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"199797","display":"prazosin 1 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"199798","display":"prazosin 2 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"199799","display":"prazosin 5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"260376","display":"terazosin 10 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312481","display":"polythiazide 0.5 MG / prazosin 1 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312482","display":"polythiazide 0.5 MG / prazosin 2 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312483","display":"polythiazide 0.5 MG / prazosin 5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312593","display":"prazosin 1 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"312594","display":"prazosin 2 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"313215","display":"terazosin 1 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"313217","display":"terazosin 2 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"313219","display":"terazosin 5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"636360","display":"24 HR doxazosin 4 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"636361","display":"24 HR doxazosin 8 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"861132","display":"24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"861402","display":"phenoxybenzamine hydrochloride 10 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"863669","display":"tamsulosin hydrochloride 0.4 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"996097","display":"dutasteride 0.5 MG / tamsulosin hydrochloride 0.4 MG Oral Capsule"}]}}